Merck
MRK
#38
Rank
NZ$654.92 B
Marketcap
NZ$265.46
Share price
2.18%
Change (1 day)
76.77%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): NZ$2.14

According to Merck's latest financial reports the company's current EPS (TTM) is NZ$2.25. In 2025 the company made an earnings per share (EPS) of NZ$12.98 an increase over its 2024 EPS that were of NZ$12.00.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$2.14-83.48%
2025NZ$12.988.15%
2024NZ$12.004308.46%
2023NZ$0.27-97.32%
2022NZ$10.1710.92%
2021NZ$9.1784.68%
2020NZ$4.97-27.2%
2019NZ$6.8263.44%
2018NZ$4.17151.11%
2017NZ$1.66-54.58%
2016NZ$3.6630.21%
2015NZ$2.81-61.99%
2014NZ$7.39180.51%
2013NZ$2.64-31.82%
2012NZ$3.876.62%
2011NZ$3.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.51 590.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.82 426.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.35-39.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$5.54 146.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.06 2,261.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$28.80 1,181.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.38 50.37%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$8.06 258.74%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.68 152.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$1.12-50.22%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel